Navegador Biosciences

Navegador Biosciences is a Portugal-based contract research organization (CRO) and biotechnology company specializing in preclinical drug discovery and development services. Operating out of Coimbra and Cantanhede, the company provides expert solutions in molecular and cellular biology, medicinal chemistry, pharmacology, and toxicology, with a focus on GLP-compliant preclinical studies, ADME/DMPK profiling, and custom assay development. In addition to its service offerings, Navegador Biosciences actively participates in international collaborative research projects, such as Eurostars-funded initiatives, to develop novel therapeutic approaches for hematological malignancies like lymphoma and acute myeloid leukemia. The company's scientific team has contributed to the preclinical evaluation of promising small-molecule candidates, including KRAS G12D and PTPN2/1 inhibitors.